AG真人官方

STOCK TITAN
  1. Home
  2. Sec-filings
  3. MXL
  4. [Form 4] MaxLinear, Inc. Insider Trading Activity

[Form 4] MaxLinear, Inc. Insider Trading Activity

Filing Impact
(Low)
Filing Sentiment
(Neutral)
Form Type
4
Rhea-AI Filing Summary

Form 4 鈥� MaxLinear, Inc. (MXL): Steven G. Litchfield

The filing reports insider equity awards for Steven G. Litchfield (Chief Financial Officer and Chief Corporate Strategy Officer). On 07/27/2025 an outstanding option was amended: the "old" option (originally granted 08/10/2018, fully vested on 07/02/2022) was cancelled and a replacement option was granted. The replacement option covers 306,000 shares with an exercise price of $18.40, exercisable on 08/10/2025 and expiring 08/10/2028. Additionally, 77,760 Restricted Stock Units (RSUs) were granted on 08/04/2025, each representing one share, vesting one-third on 05/20/2026 and annually thereafter to full vesting on 05/20/2028. The form is signed by Connie Kwong as attorney-in-fact on 08/05/2025.

Modulo 4 鈥� MaxLinear, Inc. (MXL): Steven G. Litchfield

La comunicazione segnala assegnazioni di strumenti azionari per Steven G. Litchfield (Chief Financial Officer e Chief Corporate Strategy Officer). In data 07/27/2025 猫 stata modificata un'opzione in essere: l'opzione 'vecchia' (concessa originariamente il 08/10/2018, completamente maturata il 07/02/2022) 猫 stata annullata e sostituita con una nuova opzione. La sostituzione copre 306,000 azioni con prezzo di esercizio di $18.40, esercitabile dal 08/10/2025 e con scadenza il 08/10/2028. Inoltre, sono state assegnate 77,760 Restricted Stock Units (RSU) il 08/04/2025, ciascuna rappresentante una azione, con un terzo che matura il 05/20/2026 e poi annualmente fino al pieno maturarsi il 05/20/2028. Il modulo 猫 firmato da Connie Kwong in qualit脿 di procuratore il 08/05/2025.

Formulario 4 鈥� MaxLinear, Inc. (MXL): Steven G. Litchfield

La presentaci贸n informa sobre adjudicaciones de capital a un insider para Steven G. Litchfield (Director Financiero y Chief Corporate Strategy Officer). El 07/27/2025 se modific贸 una opci贸n vigente: la opci贸n 'anterior' (otorgada originalmente el 08/10/2018, totalmente adquirida el 07/02/2022) fue cancelada y reemplazada por una nueva opci贸n. La opci贸n de reemplazo cubre 306,000 acciones con precio de ejercicio de $18.40, ejercitable a partir del 08/10/2025 y con vencimiento el 08/10/2028. Adem谩s, se adjudicaron 77,760 Restricted Stock Units (RSU) el 08/04/2025, cada una representando una acci贸n, con un tercio que vence el 05/20/2026 y el resto anualmente hasta la adquisici贸n completa el 05/20/2028. El formulario est谩 firmado por Connie Kwong como apoderada el 08/05/2025.

鞏戩嫕 4 鈥� MaxLinear, Inc. (MXL): Steven G. Litchfield

頃措嫻 鞁犼碃靹滌棎電� Steven G. Litchfield(斓滉碃鞛毂呾瀯鞛� 氚� 斓滉碃旮办梾鞝勲灥毂呾瀯鞛�)鞐� 雽�頃� 雮措秬鞛� 欤检嫕 氤挫儊鞚� 氤搓碃霅橃柎 鞛堨姷雼堧嫟. 07/27/2025鞐� 旮办〈 鞓奠厴鞚� 靾橃爼霅橃棃電旊嵃, '旮办〈' 鞓奠厴(鞗愲灅 攵�鞐澕 08/10/2018, 鞕勳爠頌� 旆摑霅� 雮犾 07/02/2022)鞚� 旆唽霅橁碃 雽�觳� 鞓奠厴鞚� 攵�鞐悩鞐堨姷雼堧嫟. 雽�觳� 鞓奠厴鞚� 306,000欤检棎 頃措嫻頃橂┌ 頄夓偓 臧�瓴╈潃 $18.40, 頄夓偓 臧�電レ澕鞚� 08/10/2025, 毵岆鞚检潃 08/10/2028鞛呺媹雼�. 霕愴暅 08/04/2025鞐� 欤茧嫻 1欤茧ゼ 雮橅儉雮措姅 77,760臧滌潣 鞝滍暅攵�欤检嫕雼渼(RSU)臧� 攵�鞐悩鞐堨溂氅�, 鞚措摛鞚� 05/20/2026鞐� 3攵勳潣 1鞚� 旆摑霅橁碃 鞚错泟 毵る厔 旆摑霅橃柎 05/20/2028鞐� 鞝勲秬 旆摑霅╇媹雼�. 頃措嫻 靹滊電� 08/05/2025鞐� Connie Kwong鞚� 雽�毽澑 鞛愱博鞙茧 靹滊獏頄堨姷雼堧嫟.

Formulaire 4 鈥� MaxLinear, Inc. (MXL): Steven G. Litchfield

Le d茅p么t signale des attributions de titres 脿 un initi茅 pour Steven G. Litchfield (Directeur financier et Chief Corporate Strategy Officer). Le 07/27/2025, une option en cours a 茅t茅 modifi茅e : l'option 'ancienne' (initialement accord茅e le 08/10/2018, enti猫rement acquise le 07/02/2022) a 茅t茅 annul茅e et remplac茅e par une nouvelle option. L'option de remplacement porte sur 306,000 actions au prix d'exercice de $18.40, exer莽able 脿 partir du 08/10/2025 et expirant le 08/10/2028. De plus, 77,760 unit茅s d'actions restreintes (RSU) ont 茅t茅 attribu茅es le 08/04/2025, chacune repr茅sentant une action, un tiers venant 脿 茅ch茅ance le 05/20/2026 puis annuellement jusqu'脿 l'acquisition compl猫te le 05/20/2028. Le formulaire est sign茅 par Connie Kwong en qualit茅 de mandataire le 08/05/2025.

Formular 4 鈥� MaxLinear, Inc. (MXL): Steven G. Litchfield

Die Einreichung meldet Insider-Beteiligungszuwendungen f眉r Steven G. Litchfield (Chief Financial Officer und Chief Corporate Strategy Officer). Am 07/27/2025 wurde eine bestehende Option ge盲ndert: die 'alte' Option (urspr眉nglich gew盲hrt am 08/10/2018, vollst盲ndig unverfallbar am 07/02/2022) wurde annulliert und durch eine Ersatzoption ersetzt. Die Ersatzoption umfasst 306,000 Aktien zu einem Aus眉bungspreis von $18.40, aus眉bbar ab dem 08/10/2025 und mit Ablaufdatum 08/10/2028. Zus盲tzlich wurden am 08/04/2025 77,760 Restricted Stock Units (RSU) gew盲hrt, jede entspricht einer Aktie; ein Drittel wird am 05/20/2026 unverfallbar und danach j盲hrlich bis zur vollst盲ndigen Unverfallbarkeit am 05/20/2028. Das Formular ist von Connie Kwong als Bevollm盲chtigte am 08/05/2025 unterzeichnet.

Positive
  • Replacement option granted: 306,000 stock options with an $18.40 exercise price, exercisable 08/10/2025 and expiring 08/10/2028
  • RSU award: 77,760 Restricted Stock Units granted 08/04/2025 with a clear vesting schedule (one-third on 05/20/2026; fully vested 05/20/2028)
  • Documentation: Filing includes explicit cancellation of prior option (original grant 08/10/2018, fully vested 07/02/2022) and is signed by attorney-in-fact on 08/05/2025
Negative
  • None.

Insights

TL;DR: The CFO received a replacement option for 306,000 shares and 77,760 RSUs with defined vesting/exercise dates.

The filing documents a compensation-related equity award and an amendment replacing a prior option. Key quantitative details are the 306,000 option award at an $18.40 exercise price (exercisable 08/10/2025, expiring 08/10/2028) and 77,760 RSUs vesting through 05/20/2028. For valuation or modeling, analysts will compare the exercise price to prevailing market prices on relevant dates and consider potential dilution impact, but those market prices are not provided in this filing.

TL;DR: The disclosure shows a standard executive equity amendment and time-based RSU grant with explicit vesting schedule.

The form explicitly states the cancellation of an earlier option (granted 08/10/2018, fully vested 07/02/2022) and the issuance of a replacement option plus RSUs. The RSU vesting schedule is fully specified: one-third on 05/20/2026 and annual one-third installments to 05/20/2028. The filing includes required signatures and identifies the reporting person as both CFO and Chief Corporate Strategy Officer. No departures, sales, or regulatory issues are disclosed in the document.

Modulo 4 鈥� MaxLinear, Inc. (MXL): Steven G. Litchfield

La comunicazione segnala assegnazioni di strumenti azionari per Steven G. Litchfield (Chief Financial Officer e Chief Corporate Strategy Officer). In data 07/27/2025 猫 stata modificata un'opzione in essere: l'opzione 'vecchia' (concessa originariamente il 08/10/2018, completamente maturata il 07/02/2022) 猫 stata annullata e sostituita con una nuova opzione. La sostituzione copre 306,000 azioni con prezzo di esercizio di $18.40, esercitabile dal 08/10/2025 e con scadenza il 08/10/2028. Inoltre, sono state assegnate 77,760 Restricted Stock Units (RSU) il 08/04/2025, ciascuna rappresentante una azione, con un terzo che matura il 05/20/2026 e poi annualmente fino al pieno maturarsi il 05/20/2028. Il modulo 猫 firmato da Connie Kwong in qualit脿 di procuratore il 08/05/2025.

Formulario 4 鈥� MaxLinear, Inc. (MXL): Steven G. Litchfield

La presentaci贸n informa sobre adjudicaciones de capital a un insider para Steven G. Litchfield (Director Financiero y Chief Corporate Strategy Officer). El 07/27/2025 se modific贸 una opci贸n vigente: la opci贸n 'anterior' (otorgada originalmente el 08/10/2018, totalmente adquirida el 07/02/2022) fue cancelada y reemplazada por una nueva opci贸n. La opci贸n de reemplazo cubre 306,000 acciones con precio de ejercicio de $18.40, ejercitable a partir del 08/10/2025 y con vencimiento el 08/10/2028. Adem谩s, se adjudicaron 77,760 Restricted Stock Units (RSU) el 08/04/2025, cada una representando una acci贸n, con un tercio que vence el 05/20/2026 y el resto anualmente hasta la adquisici贸n completa el 05/20/2028. El formulario est谩 firmado por Connie Kwong como apoderada el 08/05/2025.

鞏戩嫕 4 鈥� MaxLinear, Inc. (MXL): Steven G. Litchfield

頃措嫻 鞁犼碃靹滌棎電� Steven G. Litchfield(斓滉碃鞛毂呾瀯鞛� 氚� 斓滉碃旮办梾鞝勲灥毂呾瀯鞛�)鞐� 雽�頃� 雮措秬鞛� 欤检嫕 氤挫儊鞚� 氤搓碃霅橃柎 鞛堨姷雼堧嫟. 07/27/2025鞐� 旮办〈 鞓奠厴鞚� 靾橃爼霅橃棃電旊嵃, '旮办〈' 鞓奠厴(鞗愲灅 攵�鞐澕 08/10/2018, 鞕勳爠頌� 旆摑霅� 雮犾 07/02/2022)鞚� 旆唽霅橁碃 雽�觳� 鞓奠厴鞚� 攵�鞐悩鞐堨姷雼堧嫟. 雽�觳� 鞓奠厴鞚� 306,000欤检棎 頃措嫻頃橂┌ 頄夓偓 臧�瓴╈潃 $18.40, 頄夓偓 臧�電レ澕鞚� 08/10/2025, 毵岆鞚检潃 08/10/2028鞛呺媹雼�. 霕愴暅 08/04/2025鞐� 欤茧嫻 1欤茧ゼ 雮橅儉雮措姅 77,760臧滌潣 鞝滍暅攵�欤检嫕雼渼(RSU)臧� 攵�鞐悩鞐堨溂氅�, 鞚措摛鞚� 05/20/2026鞐� 3攵勳潣 1鞚� 旆摑霅橁碃 鞚错泟 毵る厔 旆摑霅橃柎 05/20/2028鞐� 鞝勲秬 旆摑霅╇媹雼�. 頃措嫻 靹滊電� 08/05/2025鞐� Connie Kwong鞚� 雽�毽澑 鞛愱博鞙茧 靹滊獏頄堨姷雼堧嫟.

Formulaire 4 鈥� MaxLinear, Inc. (MXL): Steven G. Litchfield

Le d茅p么t signale des attributions de titres 脿 un initi茅 pour Steven G. Litchfield (Directeur financier et Chief Corporate Strategy Officer). Le 07/27/2025, une option en cours a 茅t茅 modifi茅e : l'option 'ancienne' (initialement accord茅e le 08/10/2018, enti猫rement acquise le 07/02/2022) a 茅t茅 annul茅e et remplac茅e par une nouvelle option. L'option de remplacement porte sur 306,000 actions au prix d'exercice de $18.40, exer莽able 脿 partir du 08/10/2025 et expirant le 08/10/2028. De plus, 77,760 unit茅s d'actions restreintes (RSU) ont 茅t茅 attribu茅es le 08/04/2025, chacune repr茅sentant une action, un tiers venant 脿 茅ch茅ance le 05/20/2026 puis annuellement jusqu'脿 l'acquisition compl猫te le 05/20/2028. Le formulaire est sign茅 par Connie Kwong en qualit茅 de mandataire le 08/05/2025.

Formular 4 鈥� MaxLinear, Inc. (MXL): Steven G. Litchfield

Die Einreichung meldet Insider-Beteiligungszuwendungen f眉r Steven G. Litchfield (Chief Financial Officer und Chief Corporate Strategy Officer). Am 07/27/2025 wurde eine bestehende Option ge盲ndert: die 'alte' Option (urspr眉nglich gew盲hrt am 08/10/2018, vollst盲ndig unverfallbar am 07/02/2022) wurde annulliert und durch eine Ersatzoption ersetzt. Die Ersatzoption umfasst 306,000 Aktien zu einem Aus眉bungspreis von $18.40, aus眉bbar ab dem 08/10/2025 und mit Ablaufdatum 08/10/2028. Zus盲tzlich wurden am 08/04/2025 77,760 Restricted Stock Units (RSU) gew盲hrt, jede entspricht einer Aktie; ein Drittel wird am 05/20/2026 unverfallbar und danach j盲hrlich bis zur vollst盲ndigen Unverfallbarkeit am 05/20/2028. Das Formular ist von Connie Kwong als Bevollm盲chtigte am 08/05/2025 unterzeichnet.

SEC Form 4
FORM 4 UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940
OMB APPROVAL
OMB Number: 3235-0287
Estimated average burden
hours per response: 0.5
Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).
Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.
1. Name and Address of Reporting Person*
LITCHFIELD STEVEN G
(Last) (First) (Middle)
C/O MAXLINEAR, INC.
5966 LA PLACE COURT, SUITE 100
(Street)
CARLSBAD CA 92008
(City) (State) (Zip)
2. Issuer Name and Ticker or Trading Symbol
MAXLINEAR, INC [ MXL ] 		5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)
Director 10% Owner
X Officer (give title below) Other (specify below)
See remarks
3. Date of Earliest Transaction (Month/Day/Year)
07/27/2025
4. If Amendment, Date of Original Filed (Month/Day/Year)
 6. Individual or Joint/Group Filing (Check Applicable Line)
X Form filed by One Reporting Person
Form filed by More than One Reporting Person
Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3) 2. Transaction Date (Month/Day/Year) 2A. Deemed Execution Date, if any (Month/Day/Year) 3. Transaction Code (Instr. 8) 4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5) 5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4) 6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 7. Nature of Indirect Beneficial Ownership (Instr. 4)
Code V Amount (A) or (D) Price
Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned
(e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3) 2. Conversion or Exercise Price of Derivative Security 3. Transaction Date (Month/Day/Year) 3A. Deemed Execution Date, if any (Month/Day/Year) 4. Transaction Code (Instr. 8) 5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5) 6. Date Exercisable and Expiration Date (Month/Day/Year) 7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4) 8. Price of Derivative Security (Instr. 5) 9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4) 10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 11. Nature of Indirect Beneficial Ownership (Instr. 4)
Code V (A) (D) Date Exercisable Expiration Date Title Amount or Number of Shares
Stock Option (right to buy) $18.4 07/27/2025 D 306,000 (1) 08/10/2025 Common Stock 306,000 $0 0 D
Stock Option (right to buy) $18.4 07/27/2025 A 306,000 (1) 08/10/2028 Common Stock 306,000 $0 306,000 D
Restricted Stock Units (2) 08/04/2025 A 77,760 (3) (3) Common Stock 77,760 $0 77,760 D
Explanation of Responses:
1. The two reported transactions involved an amendment of an outstanding option, resulting in the cancellation of the "old" option and the grant of a replacement option. The option was originally granted on August 10, 2018 and became fully vested on July 2, 2022.
2. Each restricted stock unit ("RSU") represents a contingent right to receive one share of MaxLinear, Inc. Common Stock.
3. Subject to the Reporting Person's continuous status as a Service Provider (as defined in MaxLinear, Inc.'s Amended and Restated 2010 Equity Incentive Plan) on each applicable vesting date, one third (1/3rd) of the RSUs subject to the award shall vest on May 20, 2026, and one third (1/3rd) of the RSUs subject to the award vest annually on each May 20 thereafter, such that the award will be fully vested on May 20, 2028.
Remarks:
Chief Financial Officer and Chief Corporate Strategy Officer
/s/ Connie Kwong, as Attorney-in-Fact 08/05/2025
** Signature of Reporting Person Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.

Source:

FAQ

What did the MXL Form 4 filed for Steven G. Litchfield report?

The Form 4 reports the cancellation of an earlier option and the grant of a replacement option for 306,000 shares and 77,760 RSUs to Steven G. Litchfield.

What is the exercise price and exercisable date of the replacement option in the MXL filing?

The replacement option has an exercise price of $18.40, is exercisable on 08/10/2025, and expires on 08/10/2028.

When were the RSUs granted and what is their vesting schedule?

The RSUs were granted on 08/04/2025; they vest one-third on 05/20/2026 and one-third annually thereafter, fully vesting on 05/20/2028.

What prior option was altered according to the filing?

The filing states the earlier option was originally granted on 08/10/2018 and became fully vested on 07/02/2022; it was cancelled as part of the amendment.

What is the reporting person's role at MaxLinear noted on the Form 4?

The reporting person is identified as Chief Financial Officer and Chief Corporate Strategy Officer.

When was the Form 4 signed and by whom?

The form is signed by Connie Kwong, as attorney-in-fact, dated 08/05/2025.
Stock MXL logo
Maxlinear

NASDAQ:MXL

MXL Rankings

#2456 Ranked by Market Cap
N/A Ranked by Dividends

MXL Latest News

Aug 21, 2025
MaxLinear Announces New Employee Inducement Grants
Jul 29, 2025
MaxLinear, Inc. Announces Third Quarter 2025 Financial Conference Participation
Jul 29, 2025
MaxLinear to Unveil Panther V: 450Gbps Storage Accelerator for Enterprise and Hyperscale Data Centers at FMS 2025
Jul 23, 2025
MaxLinear, Inc. Announces Second Quarter 2025 Financial Results
Jul 1, 2025
MaxLinear, Inc. Announces Conference Call to Review Second Quarter 2025 Financial Results

MXL Latest SEC Filings

Aug 11, 2025
[SCHEDULE 13G] MaxLinear, Inc. SEC Filing
Aug 5, 2025
[Form 4] MaxLinear, Inc. Insider Trading Activity
Aug 5, 2025
[Form 4] MaxLinear, Inc. Insider Trading Activity
Jul 23, 2025
[10-Q] MaxLinear, Inc. Quarterly Earnings Report
Jul 23, 2025
[8-K] MaxLinear, Inc. Reports Material Event

MXL Stock Data

1.25B
81.22M
6.72%
84.1%
6.07%
Semiconductors
Semiconductors & Related Devices
United States
CARLSBAD